EICHOR
● Active Not Recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma · Sponsor: Giselle Sholler
About this study
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study in combination with etoposide for subjects with relapsed/refractory neuroblastoma.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (31)
| University of Alabama/Children's of Alabama | Birmingham, Alabama, United States | — |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | — |
| UCSF Benioff Children's Hospital Oakland | Oakland, California, United States | — |
| Rady Children's Hospital | San Diego, California, United States | — |
| Connecticut Children's Hospital | Hartford, Connecticut, United States | — |
| Arnold Palmer Hospital for Children | Orlando, Florida, United States | — |
| St. Joseph's Children's Hospital | Tampa, Florida, United States | — |
| Augusta University Health | Augusta, Georgia, United States | — |
| University of Iowa | Iowa City, Iowa, United States | — |
| Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine | Louisville, Kentucky, United States | — |
| Helen DeVos Children's Hospital | Grand Rapids, Michigan, United States | — |
| Children's Hospital and Clinics of Minnesota | Minneapolis, Minnesota, United States | — |
+ 19 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04301843